Authors:
Marsh, SGE
Bodmer, JG
Albert, ED
Bodmer, WF
Bontrop, RE
Dupont, S
Erlich, HA
Hansen, JA
Mach, B
Mayr, WR
Parham, P
Petersdorf, EW
Sasazuki, T
Schreuder, GMT
Strominger, JL
Svejgaard, A
Terasaki, PI
Citation: Sge. Marsh et al., Nomenclature for factors of the HLA system, 2000, EUR J IMM, 28(3), 2001, pp. 377-424
Authors:
Valdes, AM
Noble, JA
Genin, E
Clerget-Darpoux, F
Erlich, HA
Thomson, G
Citation: Am. Valdes et al., Modeling of HLA class II susceptibility to type I diabetes reveals an effect associated with DPB1, GENET EPID, 21(3), 2001, pp. 212-223
Citation: Mh. Crawford et al., Genetic variation among the Golla pastoral caste subdivisions of Andhra Pradesh, India, according to the HLA system, HUMAN IMMUN, 62(9), 2001, pp. 1031-1041
Authors:
Hollenbach, JA
Thomson, G
Cao, K
Fernandez-Vina, M
Erlich, HA
Bugawan, TL
Winkler, C
Winter, M
Klitz, J
Citation: Ja. Hollenbach et al., HLA diversity, differentiation, and haplotype evolution in mesoamerican natives, HUMAN IMMUN, 62(4), 2001, pp. 378-390
Authors:
Wang, SS
Wheeler, CM
Hildesheim, A
Schiffman, M
Herrero, R
Bratti, MC
Sherman, ME
Alfaro, M
Hutchinson, ML
Morales, J
Lorincz, A
Burk, RD
Carrington, M
Erlich, HA
Apple, RJ
Citation: Ss. Wang et al., Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica, J INFEC DIS, 184(10), 2001, pp. 1310-1314
Authors:
Park, YS
She, JX
Noble, JA
Erlich, HA
Eisenbarth, GS
Citation: Ys. Park et al., Transracial evidence for the influence of the homologous HLA DR-DQ haplotype on transmission of HLA DR4 haplotypes to diabetic children, TISSUE ANTI, 57(3), 2001, pp. 185-191
Authors:
Visvikis, S
Sass, C
Pallaud, C
Grow, MA
Zannad, F
Siest, G
Erlich, HA
Cheng, S
Citation: S. Visvikis et al., Familial studies on the genetics of cardiovascular diseases: the Stanislascohort (vol 38, pg 827, 2000), CLIN CH L M, 38(12), 2000, pp. 1318-1318
Citation: W. Klitz et al., Analysis of genotype frequencies and interlocus association for the PM, DQA1, and D1S80 loci in four populations, J FOREN SCI, 45(5), 2000, pp. 1009-1015
Authors:
Yu, J
Yu, LP
Bugawan, TL
Erlich, HA
Barriga, K
Hoffman, M
Rewers, M
Eisenbarth, GS
Citation: J. Yu et al., Transient antiislet autoantibodies: Infrequent occurrence and lack of association with "genetic" risk factors, J CLIN END, 85(7), 2000, pp. 2421-2428
Authors:
Park, Y
She, JX
Wang, CY
Lee, H
Babu, S
Erlich, HA
Noble, JA
Eisenbarth, GS
Citation: Y. Park et al., Common susceptibility and transmission pattern of human leukocyte antigen DRB1-DQB1 haplotypes to Korean and Caucasian patients with type 1 diabetes, J CLIN END, 85(12), 2000, pp. 4538-4542
Authors:
Redondo, MJ
Kawasaki, E
Mulgrew, CL
Noble, JA
Erlich, HA
Freed, BM
Lie, BA
Thorsby, E
Eisenbarth, GS
Undlien, DE
Ronningen, KS
Citation: Mj. Redondo et al., DR- and DQ-associated protection from type 1A diabetes: Comparison of DRB11401 and DQA1*0102-DQB1*0602, J CLIN END, 85(10), 2000, pp. 3793-3797
Citation: Tl. Bugawan et al., High-resolution HLA class I typing in the CEPH families: analysis of linkage disequilibrium among HLA loci, TISSUE ANTI, 56(5), 2000, pp. 392-404
Authors:
Mack, SJ
Bugawan, TL
Moonsamy, PV
Erlich, JA
Trachtenberg, EA
Paik, YK
Begovich, AB
Saha, N
Beck, HP
Stoneking, M
Erlich, HA
Citation: Sj. Mack et al., Evolution of Pacific/Asian populations inferred from HLA class II allele frequency distributions, TISSUE ANTI, 55(5), 2000, pp. 383-400
Authors:
Haddow, JE
Bradley, LA
Palomaki, GE
Doherty, RA
Bernhardt, BA
Brock, DJH
Cheuvront, B
Cunningham, GC
Donnenfeld, AE
Erickson, JL
Erlich, HA
Ferrie, RM
FitzSimmons, SC
Greene, MF
Grody, WW
Haddow, PK
Harris, H
Holmes, LB
Howell, RR
Katz, M
Klinger, KW
Kloza, EM
LeFevre, ML
Little, S
Loeben, G
McGovern, M
Pyeritz, RE
Rowley, PT
Saiki, RK
Short, MP
Tabone, J
Wald, NJ
Wilker, NL
Witt, DR
Citation: Je. Haddow et al., Issues in implementing prenatal screening for cystic fibrosis: Results of a working conference, GENET MED, 1(4), 1999, pp. 129-135
Authors:
Bodmer, JG
Marsh, SGE
Albert, ED
Bodmer, WF
Bontrop, RE
Dupont, B
Erlich, HA
Hansen, JA
Mach, B
Mayr, WR
Parham, P
Petersdorf, EW
Sasazuki, T
Schreuder, GMT
Strominger, JL
Svejgaard, A
Terasaki, PI
Citation: Jg. Bodmer et al., Nomenclature for factors of the HLA system, 1998, EUR J IMM, 26(2-3), 1999, pp. 81-116
Authors:
Bodmer, JG
Marsh, SGE
Albert, ED
Bodmer, WF
Bontrop, RE
Dupont, B
Erlich, HA
Hansen, JA
Mach, B
Mayr, WR
Parham, P
Petersdorf, EW
Sasazuki, T
Schreuder, GMT
Strominger, JL
Svejgaard, A
Terasaki, PI
Citation: Jg. Bodmer et al., Nomenclature for Factors of the HLA System, 1998, HUMAN IMMUN, 60(4), 1999, pp. 361-395
Authors:
Bergstrom, TF
Erlandsson, R
Engkvist, H
Josefsson, A
Erlich, HA
Gyllensten, U
Citation: Tf. Bergstrom et al., Phylogenetic history of hominoid DRB loci and alleles inferred from intronsequences, IMMUNOL REV, 167, 1999, pp. 351-365
Authors:
Pugliese, A
Kawasaki, E
Zeller, M
Yu, LP
Babu, S
Solimena, M
Moraes, CT
Pietropaolo, M
Friday, RP
Trucco, M
Ricordi, C
Allen, M
Noble, JA
Erlich, HA
Eisenbarth, GS
Citation: A. Pugliese et al., Sequence analysis of the diabetes-protective human leukocyte antigen-DQB10602 allele in unaffected, islet cell antibody-positive first degree relatives and in rare patients with type 1 diabetes, J CLIN END, 84(5), 1999, pp. 1722-1728
Authors:
Yu, LP
Brewer, KW
Gates, S
Wu, AY
Wang, T
Babu, SR
Gottlieb, PA
Freed, BM
Noble, J
Erlich, HA
Rewers, MJ
Eisenbarth, GS
Citation: Lp. Yu et al., DRB104 and DQ alleles: Expression of 21-hydroxylase autoantibodies and risk of progression to Addison's disease, J CLIN END, 84(1), 1999, pp. 328-335
Authors:
Salamon, H
Klitz, W
Easteal, S
Gao, XJ
Erlich, HA
Fernandez-Vina, M
Trachtenberg, EA
McWeeney, SK
Nelson, MP
Thomson, G
Citation: H. Salamon et al., Evolution of HLA class II molecules: Allelic and amino acid site variability across populations, GENETICS, 152(1), 1999, pp. 393-400